Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease

Journal of Korean Medical Science

Volumn 26, Issue 3, 2011, Pages 379-385

  Lee, Jae Seung ^a   Huh, Jin Won ^a   Chae, Eun Jin ^b   Seo, Joon Beom ^b   Ra, Seung Won ^c   Lee, Ji Hyun ^d   Kim, Eun Kyung ^d   Lee, Young Kyung ^e   Kim, Tae Hyung ^f   Kim, Woo Jin ^g   Lee, Jin Hwa ^h   Lee, Sang Min ⁱ   Lee, Sangyeub ^j   Lim, Seong Yong ^k   Shin, Tae Rim ^l   Yoon, Ho Il ^m   Sheen, Seung Soo ⁿ   Oh, Yeon Mok ^a   Lee, Sang Do ^a  

^a Clinical Research Center for Chronic Obstructive Airway Diseases   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d CHA University   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f Hanyang University Guri Hospital   (South Korea)

^g Kangwon National University   (South Korea)

^h Mokdong Hospital   (South Korea)

ⁱ Seoul National University College of Medicine   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k Sungkyunkwan University School of Medicine   (South Korea)

^l Hallym University College of Medicine   (South Korea)

^m Seoul National University Bundang Hospital   (South Korea)

ⁿ Ajou University School of Medicine   (South Korea)

more..

Author keywords

Adrenergic beta Agonists; Chronic obstructive; Corticosteroids; Emphysema; Pulmonary disease; Respiratory function tests

Indexed keywords

ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; SALBUTAMOL; SALMETEROL;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; FEMALE; GENERAL APPARATUS, EQUIPMENT AND SUPPLIES; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SOUTH KOREA; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; EMPHYSEMA; FEMALE; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79953757633     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.3.379     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-303.
3. Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-9.
4. Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 1084-91.
5. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-89.
6. The COPD guidelines group of the standards of care committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 Suppl 5: S1-28.
7. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003; 58: 654-8.
8. Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Kwon SY, Lee SD. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008; 186: 381-6.
9. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions: a report of the conclusions of a Ciba guest symposium. Thorax 1959; 14: 286-99.
10. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, Strachan D, Weiland SK, Williams HC. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-91.
11. Park JO, Choi IS, Park KO. Normal predicted standards of single breath carbon monoxide diffusing capacity of lung in healthy nonsmoking adults. Korean J Intern Med 1985; 28: 176-83.
12. Choi JK, Paek D, Lee JO. Normal predicted values of spirometry in Korean population. Tuberc Respir Dis 2005; 58: 230-42.
13. Quanjer P, Dalhuijsen A, Van Zoramen B. Standardized lung function testing. Report of the working party for the European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19 Suppl 5: 1-95.
14. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD; KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186: 157-65.
15. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-7.
16. Wood SA, Zerhouni EA, Hoford JD, Hoffman EA, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995; 79: 1687-97.
17. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-64.
18. Calverley P, Pauwels RA, Jones PW, Anderson JA, Vestbos J. The severity of airways obstruction as a determinant of treatment response in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 209-18.
19. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009; 10: 59.
20. Meslier N, Charbonneau G, Racineux J. Wheezes. Eur Respir J 1995; 8: 1942-8.
21. Marini JJ, Pierson DJ, Hudson LD, Lakshminarayan S. The significance of wheezing in chronic airflow obstruction. Am Rev Respir Dis 1979; 120: 1069-72.
22. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155: 1529-34.
23. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006; 100: 1742-52.
24. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-8.
25. Boschetto P, Miniati M, Miotto D, Braccioni F, De Rosa E, Bononi I, Papi A, Saetta M, Fabbri LM, Mapp CE. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J 2003; 21: 450-4.
26. Makita H, Nasuhara Y, Nagai K, Ito Y, Hasegawa M, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M; Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62: 932-7.
27. Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Kim N, Seo JB, Oh YM, Lee SD. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med 2010; 104: 542-9.
28. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, Coxson HO, Elliott WM, Hogg JC, Paré PD. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005; 171: 142-6.
29. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Stolk J, Sont JK, Jansen DF, Kerstjens HA, Postma DS, Sterk PJ; Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 499-504.
30. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176: 1179-84.